« back

NIHR HTA Programme (HTA)- Management of antipsychotic-induced sexual dysfunction

  Wednesday, 29 Mar 2023 | Funding Deadline

The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services. The commissioned workstream invites applications in response to calls for research on specific questions which have been identified and prioritised for their importance to the NHS, patients and social care.

While antipsychotics are helpful in reducing the symptoms of psychosis, it is well established that they can also cause significant side effects; one of the most frequently occurring ones is sexual dysfunction. The uncertainty of how to treat antipsychotic-induced sexual dysfunction remains and the HTA Programme continues to recognise the importance of the topic.

Deadline for proposals: 29 March 2023
Find out more here